X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13057) 13057
Newspaper Article (141) 141
Newsletter (45) 45
Book Chapter (13) 13
Dissertation (4) 4
Publication (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
Book Review (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9470) 9470
female (5794) 5794
oncology (5408) 5408
lymphocytes (5040) 5040
cancer (4813) 4813
immunotherapy (4034) 4034
animals (3989) 3989
male (3959) 3959
middle aged (3732) 3732
tumors (3594) 3594
immunology (3406) 3406
aged (3192) 3192
prognosis (2938) 2938
lymphocytes, tumor-infiltrating - immunology (2893) 2893
adult (2710) 2710
tumor-infiltrating lymphocytes (2710) 2710
mice (2706) 2706
expression (2558) 2558
t cells (2507) 2507
lymphocytes t (2249) 2249
immunohistochemistry (2100) 2100
survival (1976) 1976
melanoma (1823) 1823
pathology (1746) 1746
metastasis (1668) 1668
dendritic cells (1641) 1641
lymphocytes, tumor-infiltrating - pathology (1637) 1637
research (1628) 1628
antigens (1505) 1505
analysis (1499) 1499
chemotherapy (1483) 1483
apoptosis (1478) 1478
t-lymphocytes - immunology (1467) 1467
cd8-positive t-lymphocytes - immunology (1449) 1449
t-cells (1399) 1399
breast cancer (1391) 1391
care and treatment (1391) 1391
cell line, tumor (1383) 1383
medical prognosis (1379) 1379
aged, 80 and over (1367) 1367
immune system (1361) 1361
gene expression (1343) 1343
carcinoma (1295) 1295
inflammation (1228) 1228
patients (1228) 1228
metastases (1185) 1185
cell biology (1181) 1181
flow cytometry (1169) 1169
neoplasm staging (1162) 1162
cd8 antigen (1161) 1161
cytotoxicity (1137) 1137
neoplasms - immunology (1135) 1135
cytokines (1127) 1127
regulatory t-cells (1113) 1113
immune response (1112) 1112
medicine, research & experimental (1110) 1110
lymphocytes, tumor-infiltrating - metabolism (1101) 1101
mice, inbred c57bl (1073) 1073
health aspects (1058) 1058
cancer therapies (1015) 1015
medicine (1004) 1004
t-lymphocytes, regulatory - immunology (997) 997
immunity (966) 966
research article (965) 965
tumor microenvironment (939) 939
multidisciplinary sciences (923) 923
surgery (907) 907
development and progression (891) 891
cells (872) 872
macrophages (871) 871
proteins (857) 857
medical research (846) 846
biomarkers (842) 842
melanoma - pathology (839) 839
activation (838) 838
therapy (837) 837
neoplasms - pathology (796) 796
medicine & public health (777) 777
t-lymphocytes, cytotoxic - immunology (775) 775
melanoma - immunology (767) 767
colorectal cancer (763) 763
genetic aspects (754) 754
breast neoplasms - pathology (730) 730
treatment outcome (712) 712
t cell receptors (711) 711
ligands (709) 709
cell proliferation (704) 704
immune checkpoint (695) 695
chemical and pharmacologic phenomena (692) 692
mutation (690) 690
survival analysis (688) 688
studies (687) 687
tumor cells, cultured (683) 683
tumor microenvironment - immunology (679) 679
in-vivo (676) 676
retrospective studies (676) 676
cd4-positive t-lymphocytes - immunology (655) 655
lung cancer (651) 651
science (648) 648
cell survival (647) 647
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13117) 13117
Chinese (72) 72
Japanese (65) 65
French (37) 37
German (21) 21
Spanish (11) 11
Italian (7) 7
Hungarian (4) 4
Korean (3) 3
Polish (3) 3
Russian (3) 3
Czech (2) 2
Hebrew (2) 2
Serbian (2) 2
Turkish (2) 2
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 06/2011, Volume 108, Issue 26, pp. 10656 - 10661
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 2018, Volume 78, Issue 1, pp. 115 - 128
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2011, Volume 29, Issue 15, pp. 1949 - 1955
Journal Article
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 2019, Volume 50, Issue 1, pp. 181 - 194.e6
.... Here we examined the dynamics of the effector response of CD8+ tumor-infiltrating lymphocytes (TILs... 
checkpoint blockade | memory | immunotherapy | single-cell | exhaustion | CD8+ T cell | cancer | PD-1 | dysfunction | Tim-3 | CD8 | T cell | METASTATIC MELANOMA | RESPONSES | DIFFERENTIAL EXPRESSION | BIOCONDUCTOR PACKAGE | THERAPY | SET ENRICHMENT ANALYSIS | IMMUNOLOGY | TIM-3 | EXHAUSTION | PD-1 EXPRESSION | T-Lymphocyte Subsets - immunology | Cell Proliferation | Hepatocyte Nuclear Factor 1-alpha - genetics | Antigens, Neoplasm - immunology | Humans | Mice, Inbred C57BL | Neoplasms, Experimental - therapy | Transcriptome | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Lymphocytes, Tumor-Infiltrating - drug effects | Hepatocyte Nuclear Factor 1-alpha - metabolism | Hepatitis A Virus Cellular Receptor 2 - antagonists & inhibitors | Animals | Melanoma, Experimental | CD8-Positive T-Lymphocytes - drug effects | Immunotherapy | Neoplasms, Experimental - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Immunologic Memory - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Memory cells | Immunoglobulins | Immunological memory | Transcription factors | Tumor-infiltrating lymphocytes | Transcription | PD-1 protein | CD8 antigen | Effector cells | Principal components analysis | Lymphocytes T | Gene expression | Ribonucleic acid--RNA | Immune checkpoint | Lymphocytes | Precursors | Population | Software | Cancer | Tumors | CD8+ T cell
Journal Article
The Journal of experimental medicine, ISSN 1540-9538, 2013, Volume 210, Issue 9, pp. 1695 - 1710
Treatment with monoclonal antibody specific for cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), an inhibitory receptor expressed by T lymphocytes, has... 
EFFECTOR | MEDICINE, RESEARCH & EXPERIMENTAL | CTLA-4 BLOCKADE | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | CANCER-PATIENTS | IN-VIVO | COMBINATION IMMUNOTHERAPY | MONOCLONAL-ANTIBODY | IMMUNOLOGY | LARGE ESTABLISHED MELANOMA | GAMMA-RIV | ANTITUMOR-ACTIVITY | Fas Ligand Protein - metabolism | Lymph Nodes - pathology | Antibodies, Blocking - pharmacology | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Receptors, IgG - metabolism | T-Lymphocytes, Regulatory - immunology | Signal Transduction - immunology | Melanoma - prevention & control | Lymph Nodes - drug effects | Cell Membrane - metabolism | Clone Cells | Cell Membrane - drug effects | Tumor Microenvironment - drug effects | Phagocytes - drug effects | Mice, Inbred C57BL | Treatment Outcome | Lymph Nodes - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | Phagocytes - immunology | TNF-Related Apoptosis-Inducing Ligand - metabolism | Tumor Microenvironment - immunology | T-Lymphocytes, Regulatory - drug effects | Animals | Lymphocytes, Tumor-Infiltrating - pathology | Signal Transduction - drug effects | Melanoma - immunology | CD8-Positive T-Lymphocytes - drug effects | Antibodies, Blocking - therapeutic use | Lymphocyte Count | Mice | CD11b Antigen - metabolism | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | CD4 Antigens - metabolism | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Journal Article